Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) — Cash Flow Reinvestment Rate
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Cash Flow Reinvestment Rate of 0.77x as of September 2024, reinvesting CN¥39.75 Million (capex CN¥19.88 Million plus investments CN¥-19.87 Million) from operating cash flow of CN¥51.50 Million. Check Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Lianhuan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Jiangsu Lianhuan Pharmaceutical Co Ltd across 20 annual periods. Explore 600513 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Year-by-year capital reinvestment analysis for Jiangsu Lianhuan Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 17.17x | CN¥184.85 Million | CN¥10.77 Million | CN¥184.84 Million | ▲ +1217.5% |
| 2023 | 1.30x | CN¥209.42 Million | CN¥160.70 Million | CN¥200.66 Million | ▼ -61.3% |
| 2022 | 3.37x | CN¥429.70 Million | CN¥127.59 Million | CN¥209.02 Million | ▲ +175.7% |
| 2021 | 1.22x | CN¥168.98 Million | CN¥138.34 Million | CN¥168.92 Million | ▼ -35.6% |
| 2020 | 1.90x | CN¥174.25 Million | CN¥91.94 Million | CN¥174.18 Million | ▼ -92.5% |
| 2017 | 25.42x | CN¥92.44 Million | CN¥3.64 Million | CN¥48.64 Million | ▲ +1876.3% |
| 2016 | 1.29x | CN¥90.42 Million | CN¥70.28 Million | CN¥46.21 Million | ▲ +180.9% |
| 2015 | 0.46x | CN¥28.45 Million | CN¥62.12 Million | CN¥27.41 Million | ▲ +36.2% |
| 2014 | 0.34x | CN¥23.37 Million | CN¥69.50 Million | CN¥23.37 Million | ▼ -59.5% |
| 2013 | 0.83x | CN¥30.85 Million | CN¥37.17 Million | CN¥30.85 Million | ▲ +123.3% |
| 2012 | 0.37x | CN¥6.30 Million | CN¥16.94 Million | CN¥6.30 Million | ▼ -53.0% |
| 2011 | 0.79x | CN¥18.98 Million | CN¥24.00 Million | CN¥18.98 Million | ▼ -35.0% |
| 2010 | 1.22x | CN¥10.26 Million | CN¥8.43 Million | CN¥10.26 Million | ▲ +26.8% |
| 2009 | 0.96x | CN¥13.29 Million | CN¥13.83 Million | CN¥13.29 Million | ▼ -44.6% |
| 2008 | 1.73x | CN¥30.25 Million | CN¥17.44 Million | CN¥30.25 Million | ▼ -1.0% |
| 2007 | 1.75x | CN¥14.08 Million | CN¥8.03 Million | CN¥14.08 Million | ▼ -49.5% |
| 2006 | 3.47x | CN¥35.19 Million | CN¥10.14 Million | CN¥35.19 Million | ▲ +4.9% |
| 2005 | 3.31x | CN¥12.65 Million | CN¥3.82 Million | CN¥12.65 Million | ▲ +114.2% |
| 2004 | 1.54x | CN¥5.24 Million | CN¥3.39 Million | CN¥5.24 Million | ▲ +397.1% |
| 2002 | 0.31x | CN¥5.97 Million | CN¥19.22 Million | CN¥5.97 Million | — |